Table of Content

1 Market
1.1 Product Definition
1.2 Inclusion and Exclusion

2 Market Scope
2.1 Key Questions Answered in the Report

3 Research Methodology
3.1 Data Sources
3.1.1 Primary Data Source
3.1.2 Secondary Data Sources
3.2 Market Estimation Model
3.3 Criteria for Company Profiling

4 Market Overview
4.1 Introduction
4.2 Phosphoramidite Synthesis Process
4.2.1 Stability Considerations for Phosphoramidite
4.3 Applications of Phosphoramidite Chemistry
4.4 Future Trends in Phosphoramidite Industry
4.5 COVID-19 Impact on Phosphoramidite Industry
4.6 Current Market Size and Growth Potential, $Million, 2022-2032

5 Industry Insights
5.1 Overview
5.2 Regulatory Considerations for Phosphoramidite
5.2.1 Challenges
5.2.2 Current Regulatory Landscape
5.2.3 GMP, Control Strategy, and Facility Considerations
5.2.3.1 Brief Control Strategy

6 Market Dynamics
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.3.1 Increasing Synthetic Nucleotide Applications in Therapeutics
6.3.2 Growth in Synthetic Biology
6.4 Market Restraints
6.4.1 Challenges in Developing Long Nucleotide Sequences
6.4.2 Competition from Emerging DNA Synthesis Technologies
6.5 Market Opportunities
6.5.1 Utilize advanced tools for lowering manufacturing cost and increasing production in gene synthesis

7 Global Phosphoramidite Market, by Type, $Million, 2021-2032
7.1 Overview
7.2 DNA Phosphoramidites
7.3 RNA Phosphoramidites
7.4 Labeled Phosphoramidites
7.5 Other Phosphoramidites

8 Global Phosphoramidite Market, by End Users, $Million, 2021-2032
8.1 Overview
8.2 Pharmaceutical and Biotechnology Companies
8.3 Diagnostic Laboratories
8.4 Synthetic Biology and Research Institutes

9 Global Phosphoramidite Market, by Region, $Million, 2021-2032
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest-of-Asia-Pacific
9.5 Rest-of-the-World

10 Competitive Insights
10.1 Key Strategies and Development
10.1.1 Overview
10.1.2 Business Expansions
10.1.3 Mergers and Acquisitions
10.1.4 Funding Activities
10.1.5 Others
10.2 Market Share Analysis (by Company) 2021

11 Market - Competitive Benchmarking & Company Profiles
11.1 Overview
11.2 Biosynth Carbosynth
11.2.1 Company Overview
11.2.2 Role of Biosynth Carbosynth in the Global Phosphoramidite Market
11.2.3 Key Competitors of the Company
11.2.4 Corporate strategies
11.2.4.1 Synergistic Activities
11.2.5 Analyst Perspective
11.3 Bioneer Corporation
11.3.1 Company Overview
11.3.2 Role of Bioneer Corporation in the Global Phosphoramidite Market
11.3.3 Key Competitors of the Company
11.3.4 Analyst Perspective
11.4 Lumiprobe Corporation
11.4.1 Company Overview
11.4.2 Role of Lumiprobe Corporation in the Global Phosphoramidite Market
11.4.3 Key Competitors of the Company
11.4.4 Analyst Perspective
11.5 QIAGEN N.V.
11.5.1 Company Overview
11.5.2 Role of QIAGEN N.V. in the Global Phosphoramidite Market
11.5.3 Key Competitors of the Company
11.5.4 Financials
11.5.5 Analyst Perspective
11.6 Danaher Corporation (IDT)
11.6.1 Company Overview
11.6.2 Role of Danaher Corporation (IDT) in the Global Phosphoramidite Market
11.6.3 Key Competitors of the Company
11.6.4 Key Customers of the Company
11.6.5 Financials
11.6.6 Analyst Perspective
11.7 TriLink BioTechnologies
11.7.1 Company Overview
11.7.2 Role of TriLink BioTechnologies in the Global Phosphoramidite Market
11.7.3 Key Competitors of the Company
11.7.4 Financials
11.7.5 Business Strategies
11.7.6 Analyst Perspective
11.8 Creative Biolabs
11.8.1 Company Overview
11.8.2 Role of Creative Biolabs in the Global Phosphoramidite Market
11.8.3 Key Competitors of the Company
11.9 PolyOrg, Inc.
11.9.1 Company Overview
11.9.2 Role of PolyOrg, Inc. in the Global Phosphoramidite Market
11.9.3 Key Competitors of the Company
11.1 Hongene Biotech Corporation
11.10.1 Company Overview
11.10.2 Role of Hongene Biotech Corporation in the Global Phosphoramidite Market
11.10.3 Key Competitors of the Company
11.10.4 Business Strategies
11.11 ChemGenes
11.11.1 Company Overview
11.11.2 Role of ChemGenes in the Global Phosphoramidite Market
11.11.3 Key Competitors of the Company
11.12 BOC Sciences
11.12.1 Company Overview
11.12.2 Role of BOC Sciences in the Global Phosphoramidite Market
11.12.3 Key Competitors of the Company
11.12.4 Key Customers of the Company
11.13 Tokyo Chemical Industry Co., Ltd. (TCI)
11.13.1 Company Overview
11.13.2 Role of Tokyo Chemical Industry Co., Ltd. in the Global Phosphoramidite Market
11.13.3 Key Competitors of the Company
11.14 LGC Science Group Holdings Limited
11.14.1 Company Overview
11.14.2 Role of LGC Science Group Holdings Limited in the Global Phosphoramidite Market
11.14.3 Key Competitors of the Company
11.14.4 Key Customers of the Company
11.14.5 Financials
11.14.6 Business Strategies
11.14.7 Analyst Perspective
11.15 AAT Bioquest, Inc.
11.15.1 Company Overview
11.15.2 Role of AAT Bioquest, Inc. in the Global Phosphoramidite Market
11.15.3 Key Competitors of the Company
11.16 Thermo Fisher Scientific, Inc.
11.16.1 Company Overview
11.16.2 Role of Thermo Fisher Scientific, Inc. in the Global Phosphoramidite Market
11.16.3 Key Competitors of the Company
11.16.4 Financials
11.16.5 Analyst Perspective
11.17 Merck KGaA
11.17.1 Company Overview
11.17.2 Role of Merck KGaA in the Global Phosphoramidite Market
11.17.3 Key Competitors of the Company
11.17.4 Financials
11.17.5 Analyst Perspective
List of Figures
Figure 1: Global Phosphoramidite Market Dynamics
Figure 2: Global Phosphoramidite Market (by Type), $Million, 2021 and 2032
Figure 3: Global Phosphoramidite Market (by End User), $Million, 2021 and 2032
Figure 4: Global Phosphoramidite Market (by Region), $Million, 2021-2032
Figure 5: Global Phosphoramidite Market Segmentation
Figure 6: Global Phosphoramidite Market Research Methodology
Figure 7: Primary Research Methodology
Figure 8: Volume-Based Market Sizing and Forecasting Methodology
Figure 9: Structure of a Standard 2’-Deoxyadenosine Phosphoramidite
Figure 10: Workflow of Phosphoramdite Synthesis Chemistry to Produce Oligonucleotides
Figure 11: Phosphoramidite Synthesis Cycle
Figure 12: Factors Impacting the Stability of Phosphoramidites
Figure 13: Phosphoramidite Key Application Areas
Figure 14: Global Phosphoramidite Market, $Million, 2021-2032
Figure 15: Challenges for Phosphoramidite as a Drug Product
Figure 16: Control Strategy: Phosphoramidite Elements
Figure 17: Elements of Microbial Control Strategy
Figure 18: Details of GMP, Control Strategy, and Facility Considerations
Figure 19: Market Dynamics
Figure 20: Impact Analysis
Figure 21: Factors Influencing Rise in Oligonucleotide Demand and Growing Market
Figure 22: Breakthrough Achievements in Synthetic Biology, 2016-2020
Figure 23: Key Competitors Impacting Global Phosphoramidite Market Growth in Future
Figure 24: Share of Global Phosphoramidite Market (by Type), $Million, 2021 and 2032
Figure 25: Characteristics of DNA Phosphoramidites
Figure 26: Global Phosphoramidite Market (DNA Phosphoramidites), $Million, 2021-2032
Figure 27: Global Phosphoramidite Market (RNA Phosphoramidites), $Million, 2021-2032
Figure 28: Global Phosphoramidite Market (Labeled Phosphoramidites), $Million, 2021-2032
Figure 29: Global Phosphoramidite Market (Other Phosphoramidites), $Million, 2021-2032
Figure 30: Share of Global Phosphoramidite Market (by End User), $Million, 2021 and 2032
Figure 31: Global Phosphoramidite Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 32: Global Phosphoramidite Market (Diagnostic Laboratories), $Million, 2021-2032
Figure 33: Global Phosphoramidite Market (Synthetic Biology and Research Institutes), $Million, 2021-2032
Figure 34: Global Phosphoramidite Market (by Region), $Million, 2021-2032
Figure 35: Market Dynamics of North America Phosphoramidite Market
Figure 36: North America Phosphoramidite Market, $Million, 2021-2032
Figure 37: Projections of the Older Adult Population in the U.S.: 2016 to 2060 (Million)
Figure 38: U.S. Phosphoramidite Market, $Million, 2021-2032
Figure 39: Canada Phosphoramidite Market, $Million, 2021-2032
Figure 40: Market Dynamics of Europe Phosphoramidite Market
Figure 41: Europe Phosphoramidite Market, $Million, 2021-2032
Figure 42: U.K. Phosphoramidite Market, $Million, 2021-2032
Figure 43: Germany Phosphoramidite Market, $Million, 2021-2032
Figure 44: France Phosphoramidite Market, $Million, 2021-2032
Figure 45: Spain Phosphoramidite Market, $Million, 2021-2032
Figure 46: Italy Phosphoramidite Market, $Million, 2021-2032
Figure 47: Rest-of-Europe Phosphoramidite Market, $Million, 2021-2032
Figure 48: Market Dynamics of the Asia-Pacific Phosphoramidite Market
Figure 49: Asia-Pacific Phosphoramidite Market, $Million, 2021-2032
Figure 50: Japan Phosphoramidite Market, $Million, 2021-2032
Figure 51: China Phosphoramidite Market, $Million, 2021-2032
Figure 52: India Phosphoramidite Market, $Million, 2021-2032
Figure 53: Rest-of-APAC Phosphoramidite Market, $Million, 2021-2032
Figure 54: Rest-of-the-World Phosphoramidite Market, $Million, 2021-2032
Figure 55: Figure: Share of Key Developments, January 2019-August 2022
Figure 56: Business Expansions (by Company), January 2019-August 2022
Figure 57: Merger and Acquisition Activities (by Company), January 2019-August 2022
Figure 58: Market Share Analysis for the Global Phosphoramidite Market, 2021
Figure 59: Total Number of Companies Profiled
Figure 60: Bioneer Corporation’s Phosphoramidite Manufacturing Capacity
Figure 61: Bioneer Corporation: Selective Product Portfolio
Figure 62: Lumiprobe Corporation: Selective Product Portfolio
Figure 63: QIAGEN N.V.: Selective Product Profile
Figure 64: QIAGEN N.V.: Overall Financials, 2019-2021
Figure 65: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 66: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
Figure 67: QIAGEN N.V.: R&D Expenditure, 2019-2021
Figure 68: Danaher Corporation (IDT): Selective Product Portfolio
Figure 69: Danaher Corporation (IDT): Overall Financials, $Million, 2019-2021
Figure 70: Danaher Corporation (IDT): Revenue (by Segment), $Million, 2019-2021
Figure 71: Danaher Corporation (IDT): Revenue (by Region), $Million, 2019-2021
Figure 72: Danaher Corporation (IDT), R&D Expenditure, $Million, 2019-2021
Figure 73: TriLink BioTechnologies: Selective Product Portfolio
Figure 74: Maravai LifeSciences Holdings, Inc.: Overall Financials, $Million, 2019-2021
Figure 75: Maravai LifeSciences Holdings, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 76: Maravai LifeSciences Holdings, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 77: Maravai LifeSciences Holdings, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 78: Creative Biolabs: Selective Product Portfolio
Figure 79: PolyOrg, Inc.: Selective Product Portfolio
Figure 80: Hongene Biotech Corporation: Selective Product Portfolio
Figure 81: ChemGenes: Selective Product Portfolio
Figure 82: BOC Sciences: Selective Product Portfolio
Figure 83: Tokyo Chemical Industry Co., Ltd.: Selective Product Portfolio
Figure 84: LGC Science Group Holdings Limited: Selective Product Portfolio
Figure 85: LGC Science Group Holdings Limited: Overall Financials, $Million, 2019-2021
Figure 86: LGC Science Group Holdings Limited: Revenue (by Region), $Million, 2019-2021
Figure 87: AAT Bioquest, Inc.: Selective Product Portfolio
Figure 88: Thermo Fisher Scientific, Inc.: Selective Product Portfolio
Figure 89: Thermo Fisher Scientific, Inc.: Overall Financials, 2019-2021
Figure 90: Thermo Fisher Scientific, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 91: Thermo Fisher Scientific, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 92: Thermo Fisher Scientific, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 93: Merck KGaA: Selective Product Portfolio
Figure 94: Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 95: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
Figure 96: Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 97: Merck KGaA: R&D Expenditure, $Million, 2019-2021
List of Tables
Table 1: Companies and COVID-19 Impact
Table 2: Guideline Summary for Phosphoramidites
Table 3: Decreased Coupling Efficiency with Extending Oligonucleotide Sequence
Table 4: Key Characteristics of Enzymatic-based and Phosphoramidite Synthesis
Table 5: Examples of RNA Phosphoramidites
Table 6: List of Approved Oligonucleotide-Based Therapies, 1998-2020